ES2169030T3 - Envases de anticonceptivos que contienen estrogeno y progestina. - Google Patents

Envases de anticonceptivos que contienen estrogeno y progestina.

Info

Publication number
ES2169030T3
ES2169030T3 ES93107794T ES93107794T ES2169030T3 ES 2169030 T3 ES2169030 T3 ES 2169030T3 ES 93107794 T ES93107794 T ES 93107794T ES 93107794 T ES93107794 T ES 93107794T ES 2169030 T3 ES2169030 T3 ES 2169030T3
Authority
ES
Spain
Prior art keywords
progestine
strogen
packaging containers
containers containing
progestin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93107794T
Other languages
English (en)
Inventor
Robert F Casper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jencap Research Ltd
Original Assignee
Jencap Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25671520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2169030(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA 547744 external-priority patent/CA1332228C/en
Priority claimed from CA000547743A external-priority patent/CA1332227C/en
Application filed by Jencap Research Ltd filed Critical Jencap Research Ltd
Application granted granted Critical
Publication of ES2169030T3 publication Critical patent/ES2169030T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Abstract

ESTE INVENTO SE REFIERE A UNA FORMULACION CONTRACEPTIVA Y UN METODO DE CONTRACEPCION QUE EMPLEA UNA COMBINACION DE ESTROGENO Y PROGESTINA Y EN DONDE UN PERIODO CORTO DE ACTIVIDAD ESTROGENICA RELATIVAMENTE DOMINANTE SE ALTERNA CON UN PERIODO CORTO DE ACTIVIDAD PROGESTAGENICA RELATIVAMENTE DOMINANTE. EL INVENTO SE REFIERE TAMBIEN A FORMULACION DE SUSTITUCION HORMONAL PARA USO EN MUJERES MENOPAUSICAS O QUE HAN SUFRIDO ABLACION; DICHA FORMULACION EMPLEA UNA COMBINACION SIMILAR DE ESTROGENO Y PROGESTINA.
ES93107794T 1987-09-24 1988-09-23 Envases de anticonceptivos que contienen estrogeno y progestina. Expired - Lifetime ES2169030T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA 547744 CA1332228C (en) 1987-09-24 1987-09-24 Formulation and method for estrogen replacement therapy
CA000547743A CA1332227C (en) 1987-09-24 1987-09-24 Oral contraceptive formulation

Publications (1)

Publication Number Publication Date
ES2169030T3 true ES2169030T3 (es) 2002-07-01

Family

ID=25671520

Family Applications (2)

Application Number Title Priority Date Filing Date
ES88308840T Expired - Lifetime ES2061672T3 (es) 1987-09-24 1988-09-23 Preparado hormonal y su uso.
ES93107794T Expired - Lifetime ES2169030T3 (es) 1987-09-24 1988-09-23 Envases de anticonceptivos que contienen estrogeno y progestina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES88308840T Expired - Lifetime ES2061672T3 (es) 1987-09-24 1988-09-23 Preparado hormonal y su uso.

Country Status (13)

Country Link
EP (2) EP0309263B1 (es)
JP (2) JP3314207B2 (es)
KR (1) KR0170764B1 (es)
CN (1) CN1042296C (es)
AT (1) ATE209919T1 (es)
AU (2) AU630334B2 (es)
DE (2) DE3888269T2 (es)
DK (1) DK174071B1 (es)
ES (2) ES2061672T3 (es)
FI (1) FI101601B (es)
HU (1) HU214598B (es)
NO (1) NO301689B1 (es)
NZ (1) NZ226316A (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases
DE4104385C1 (es) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
US5340586A (en) * 1991-04-12 1994-08-23 University Of Southern California Methods and formulations for use in treating oophorectomized women
CA2152780A1 (en) * 1992-12-28 1994-07-07 Robert F. Casper Transdermal hormone replacement therapy
WO1994016709A2 (en) * 1993-01-19 1994-08-04 Endorecherche Inc. Therapeutic uses and delivery systems of dehydroepiandrosterone
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4405591C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonsubstitution
DE4405590C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonbehandlung
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
WO1998004268A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
EP1007052B1 (en) * 1997-08-27 2004-10-13 Ortho-McNeil Pharmaceutical, Inc. Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
DE19831263A1 (de) * 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
DE19911799A1 (de) * 1999-03-17 2000-09-28 Lohmann Therapie Syst Lts Sammelpackung zur Entnahme von befüllten Beuteln in vorgebener Reihenfolge
AU2005201151B2 (en) * 1999-03-30 2008-01-10 Jencap Research Ltd Low dose estrogen interrupted hormone replacement therapy
CA2267743C (en) 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
DE19934433A1 (de) 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
MXPA02002186A (es) * 1999-08-31 2002-09-02 Jenapharm Gmbh Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos.
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
JP2005519961A (ja) * 2002-03-11 2005-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 継続的スルファターゼ阻害プロゲストゲンホルモン補充療法
UA82851C2 (en) * 2002-08-28 2008-05-26 Estrogen replacement regimen in menopausal women
HUP0301981A2 (hu) * 2003-06-30 2005-04-28 Richter Gedeon Vegyészeti Gyár Rt. Tiszta d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-3E- és 3Z-oxim izomerek, valamint eljárás az izomer keverékek és a tiszta izomerek előállítására
US7816546B2 (en) 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
JP5288796B2 (ja) * 2004-07-07 2013-09-11 ワイス・エルエルシー 周期的プロゲスチンレジメン及びキット
CA2830984C (en) * 2011-03-25 2020-02-11 Universite Laval Inhibitors of 17.beta.-hsd1, 17.beta.-hsd3 and 17.beta.-hsd10.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
US4291028A (en) * 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
AU581486B2 (en) * 1985-12-30 1989-02-23 Warner-Lambert Company Graduated estrogen contraceptive
FR2589735A1 (fr) * 1985-11-07 1987-05-15 Beillon Xavier Compositions anticonceptionnelles contenant un oestrogene et un progestatif
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women

Also Published As

Publication number Publication date
EP0559240A2 (en) 1993-09-08
KR0170764B1 (ko) 1999-02-01
CN1042296C (zh) 1999-03-03
DK529688D0 (da) 1988-09-23
NZ226316A (en) 1991-10-25
DE3888269D1 (de) 1994-04-14
DE3888269T2 (de) 1994-07-07
FI101601B1 (fi) 1998-07-31
DK174071B1 (da) 2002-05-21
NO884230L (no) 1989-03-28
KR890004723A (ko) 1989-05-09
JP3208482B2 (ja) 2001-09-10
DE3856508T2 (de) 2002-06-06
HU214598B (hu) 1998-04-28
FI884378A0 (fi) 1988-09-23
IE20030160A1 (en) 2003-07-09
HUT50043A (en) 1989-12-28
ES2061672T3 (es) 1994-12-16
CN1041528A (zh) 1990-04-25
FI884378A (fi) 1989-03-25
EP0309263A3 (en) 1989-08-02
EP0309263B1 (en) 1994-03-09
NO301689B1 (no) 1997-12-01
JPH01132523A (ja) 1989-05-25
EP0559240A3 (en) 1993-12-22
EP0559240B1 (en) 2001-12-05
JPH11286446A (ja) 1999-10-19
EP0309263A2 (en) 1989-03-29
FI101601B (fi) 1998-07-31
DK529688A (da) 1989-05-25
DE3856508D1 (de) 2002-01-17
AU630334B2 (en) 1992-10-29
AU3044892A (en) 1993-02-11
ATE209919T1 (de) 2001-12-15
NO884230D0 (no) 1988-09-23
AU2276088A (en) 1989-04-06
JP3314207B2 (ja) 2002-08-12

Similar Documents

Publication Publication Date Title
ES2169030T3 (es) Envases de anticonceptivos que contienen estrogeno y progestina.
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
FI922206A0 (fi) Osmotisk, oral doseringsform foer fertilitets kontroll.
NL300025I1 (nl) Combinatie doseringsvorm voor vrouwen in de pre-menopauze.
BR9306005A (pt) Método e kit de estrogénio/progestina/antiprogestina para contracepçao oral e regulaçao da menstruaçao
EP0599822A3 (en) Process for the preparation and use of antigens from the pellucida zone and antibodies for sterilization and contraception.
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
NL300004I1 (nl) Voor de behandeling van oestrogeentekorten geschikte samenstelling.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559240

Country of ref document: ES